Coqueret, Olivier
Olivier Coqueret
VIAF ID: 205979879 (Personal)
Permalink: http://viaf.org/viaf/205979879
Preferred Forms
- 100 1 _ ‡a Coqueret, Olivier
- 100 0 _ ‡a Olivier Coqueret
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
The aurora A kinase as new target for chemotherapeutic agents : application treatment of colorectal cancers.. | |
c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1 | |
Cell cycle and cell death associates in western France. | |
Les cellules sénecentes comme niche de survie : rôle de la voie TSP1-CD47 | |
Chemotherapy escape and emergence of more aggressive cells : A critical role for tumoral heterogeneity. | |
Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneity | |
Circulating miRNAs as new activators of the JAK-STAT3 pathway | |
Curcumin Treatment Identifies Therapeutic Targets within Biomarkers of Liver Colonization by Highly Invasive Mesothelioma Cells-Potential Links with Sarcomas | |
Cyclin D1 represses STAT3 activation through a Cdk4-independent mechanism. | |
DNA binding by cut homeodomain proteins is down-modulated by casein kinase II | |
Echappement à la chimiothérapie et émergence de cellules plus agressives : Importance de l'hétérogénéité tumorale | |
The ectonucleotidase CD39 in the acquisition of an immunosuppressive phenotype by tumor-associated macrophages. | |
EFFECT OF BETA2-ADRENOCEPTOR AGONISTS ON HUMAN IGE PRODUCTION. | |
EFFETS DES COMPOSES BETA2-ADRENERGIQUES SUR LA PRODUCTION D'IGE | |
Escape from p21-mediated oncogene-induced senescence leads to cell dedifferentiation and dependence on anti-apoptotic Bcl-xL and MCL1 proteins. | |
Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a | |
O-GlcNAcylation Links Nutrition to the Epigenetic Downregulation of UNC5A during Colon Carcinogenesis | |
Glioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties. | |
How should we define STAT3 as an oncogene and as a potential target for therapy? | |
Identification of a new regulator and a new function of cellular senescence. | |
Imidacloprid and thiacloprid neonicotinoids bind more favourably to cockroach than to honeybee α6 nicotinic acetylcholine receptor: insights from computational studies. | |
Implication of BRG1 and cdk9 in the STAT3-mediated activation of the p21waf1 gene | |
Importance of the Cdk4-Ezh2 pathway in the senescence escape. | |
Influence of Cancer-Associated Fibroblasts (CAFs) on resistance to apoptosis in breast cancer. | |
Inhibition of Stat3 by peptide aptamer rS3-PA enhances growth suppressive effects of irinotecan on colorectal cancer cells. | |
Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells. | |
Kaposi sarcoma-associated viral cyclin K overrides cell growth inhibition mediated by oncostatin M through STAT3 inhibition | |
Linking cyclins to transcriptional control. | |
Modèles précliniques d'étude du mésothéliome : application à l'évaluation de la virothérapie anti-tumorale in vivo | |
Molecular characterization of senescence escape mechanims : definition of senescence heterogeneity. | |
New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? | |
NF-KB2, régulateur de l'autophagie dans le cancer colorectal implication dans la sénescence induite par RAS et la chimiothérapie | |
The of STAT3 transcription factors in the topoisomerase inhibitor response : implication in the chemotherapeutic treatment resistance. | |
Olfactomedin-4 is a candidate biomarker of solid gastric, colorectal, pancreatic, head and neck, and prostate cancers. | |
Oncogenic functions of STAT5 : role in the regulation of oxidative metabolism. | |
Possible role of CD23 in allergic diseases | |
Prediction of Recurrence and Survival for Triple-Negative Breast Cancer (TNBC) by a Protein Signature in Tissue Samples | |
The proteome of tumors colorectal. | |
RAS oncogene and colorectal cancer : study of the oncogenic stress response and senescence bypass.. | |
Régulation de l'activité transcriptionnelle du facteur STAT3 : l'exemple du gène p21waf1 | |
Réponse à la chimiothérapie et progression du cycle cellulaire rôle de l'oncogène STAT3 dans le cancer colorectal | |
Rôle de la kinase Akt dans la chimiorésistance : Régulation de l'équilibre Apoptose-Sénescence | |
Rôle des signaux pro-survie du récepteur Fas/CD95 dans le cancer colorectal : importance du dialogue moléculaire entre Fas et l'EGFR (Epidermal Growth Factor Receptor) | |
Rôle du calcium et de son homéostasie dans la sénescence cellulaire et ses effets paracrines : implication de la protéine tamponnant le calcium, CALB1 | |
The role of cyclin D1 in lymphopoiesis | |
Role of OLFM4, a secreted protein, in colorectal and mammary carcinogenesis : Influence of cellular background.. | |
Selective type IV phosphodiesterase inhibitors prevent IL-4-induced IgE production by human peripheral blood mononuclear cells | |
Senescent cells as survival niche : impact of TSP1-CD47 signalling. | |
STAT3 as a new autophagy regulator | |
The STAT3 oncogene as a predictive marker of drug resistance. | |
The STAT3 transcription factor is a target for the Myc and riboblastoma proteins on the Cdc25A promoter. | |
Transcriptional regulation by a DNA-associated form of cyclin D1. | |
[Transient transformation as a permanent oncogenic loop]. | |
Two-step OFFGEL approach for effective peptide separation compatible with iTRAQ labeling |